Correlates of patient acceptance of the cardioverter defibrillator: Cross-validation of the Florida patient acceptance survey in Danish patients

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 9, 2008, Pages 1168-1177

  Pedersen, Susanne S ^a   Spindler, Helle ^b   Johansen, Jens B ^b   Mortensen, Peter T ^b   Sears, Samuel F ^c  

^a TILBURG UNIVERSITY   (Netherlands)

^b AARHUS UNIVERSITY   (Denmark)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Anxiety; Depressive symptoms; Florida patient acceptance survey; Implantable cardioverter defibrillator; Type D personality

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFIBRILLATOR; DEPRESSION; FEMALE; HEALTH SURVEY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; QUALITY OF LIFE;

ANXIETY; DATA COLLECTION; DEFIBRILLATORS, IMPLANTABLE; DENMARK; DEPRESSION; FEMALE; FLORIDA; HEART FAILURE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 50549090148     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01158.x     Document Type: Article

References (38)

1. Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003 7 : 5 13.
2. Higgins SL. Impact of the multicenter automatic defibrillator implantation trial on implantable cardioverter defibrillator indication trends. Am J Cardiol 1999 83 : 79D 82D.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
4. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, et al. Multicenter InSync ICD randomized clinical evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003 289 : 2685 2694.
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. on behalf of The CARE-HF study investigators. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure: The cardiac resynchronization-heart failure (CARE-HF) trial extension phase. Eur Heart J 2006 27 : 1928 1932.
6. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002 87 : 488 493.
7. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006 29 : 619 626.
8. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality: A determinant of anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004 66 : 714 719.
9. Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999 9 : 163 168.
10. Whang W, Albert CM, Sears SF Jr., Lampert R, Conti JB, Wang PJ, Singh JP, et al. TOVA study investigators. Depression as a predictor for appropriate shocks among patients with implantable-cardioverter defibrillators. J Am Coll Cardiol 2005 45 : 1090 1095.
11. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002 106 : 1800 1805.
12. Burns JL, Sears SF, Sotile R, Schwartzman DS, Hoyt RH, Alvarez LG, Ujhelyi MR. Do patients accept implantable atrial defibrillation therapy? Results from the patient atrial shock survey of acceptance and tolerance (PASSAT) study. J Cardiovasc Electrophysiol 2004 15 : 286 291.
13. Groeneveld PW, Matta MA, Suh JJ, Yang F, Shea JA. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol 2007 30 : 463 471.
14. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005 16 : 384 390.
15. Johansen JB, Pedersen SS, Spindler H, Andersen K, Nielsen JC, Mortensen PT. Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety and depression in ICD patients: A single-centre, cross-sectional study in 610 patients. Europace 2008 10 : 545 551.
16. Hardware statistics - ICDs. Pacing Clin Electrophysiol 2000 23 : S88 S93.
17. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: Content, reliability and validity of a new measure - the Minnesota Living With Heart Failure Questionnaire. Heart Fail 1987 3 : 198 209.
18. Herdman M, Fox-Rushby J, Badia X. A model of equivalence in the cultural adaption of HRQOL instruments: The universalist approach. Qual Life Res 1998 7 : 323 335.
19. Frizelle DJ, Lewin B, Kaye G, Moniz-Cook ED. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: The ICDC. Br J Health Psychol 2006 11 : 293 301.
20. Pedersen SS, Van Domburg RT, Theuns DAMJ, Jordaens L, Erdman RA. Concerns about the implantable cardioverter defibrillator: A determinant of anxiety and depressive symptoms independent of shocks. Am Heart J 2005 149 : 664 669.
21. Denollet J. DS14: Standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005 67 : 89 97.
22. Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van Domburg RT. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 2006 171 177.
23. Emons WHM, Meijer RR, Denollet J. Negative affectivity and social inhibition in cardiovascular disease: Evaluating Type D personality and its assessment using item response theory. J Psychosom Res 2007 63 : 27 39.
24. Martens EJ, Kupper N, Pedersen SS, Aquarius AE, Denollet J. Type-D personality is a stable taxonomy in post-MI patients over an 18-month period. J Psychosom Res 2007 63 : 545 550.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 370.
26. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: An updated literature review. J Psychosom Res 2002 52 : 69 77.
27. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Every NR, Spertus JA. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003 145 : 493 499.
28. Briggs S R, Cheek M. The role of factor analysis in the development and evaluation of personality scales. J Personality 1986 54 : 106 148.
29. Clark LA, Watson D. Constructing validity: Basic issues in objective scale development. Psychol Assess 1995 7 : 309 319.
30. Pedersen SS, Theuns DA, Muskens-Heemskerk A, Erdman RA, Jordaens L. Type-D personality but not ICD indication is associated with impaired health-related quality of life 3 months post implantation. Europace 2007 9 : 675 680.
31. Pedersen SS, Theuns DA, Erdman RA, Jordaens L. Clustering of device-related concerns and Type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 2008 31 : 20 27.
32. Pedersen SS, Spindler H, Erdman RAM, Denollet J. Poor perceived social support in ICD patients and their partners: Cross-validation of the Multidimensional Scale of Perceived Social Support. Psychosomatics, In Press.
33. Sears SF, Serber ER, Lewis TS, Walker RL, Conners N, Lee JT, Curtis AB, et al. Do positive health expectations and optimism relate to quality of life outcomes for the patient with an implantable cardioverter defibrillator J Cardiopulm Rehab 2004 24 : 324 331.
34. Wathen M. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies. Am Heart J 2007 153 : S44 S52.
35. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable- cardioverter defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFree RX II) trial results. Circulation 2004 110 : 2591 2596.
36. Pedersen SS, Van Den Broek KC, Sears SF, Jr. Psychological intervention following implantation of an implantable defibrillator: A review and future recommendations. Pacing Clin Electrophysiol 2007 30 : 1546 1554.
37. Hevey D, McGee HM, Horgan J. Responsiveness of health-related quality of life outcome measures in cardiac rehabilitation: Comparison of cardiac rehabilitation outcome measures. J Consult Clin Psychol 2004 72 : 1175 1180.
38. Sears SF, Sowell LD, Kuhl EA, Kovacs AH, Serber ER, Handberg E, Kneipp SM, et al. The ICD shock and stress management program: A randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol 2007 30 : 858 864.